Cargando…
Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy
First described almost two decades ago, the pioneering yeast models of neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's diseases, have become well-established research tools, providing both basic mechanistic insights as well as a platform for the devel...
Autores principales: | Rencus-Lazar, Sigal, DeRowe, Yasmin, Adsi, Hanaa, Gazit, Ehud, Laor, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439353/ https://www.ncbi.nlm.nih.gov/pubmed/30968029 http://dx.doi.org/10.3389/fmolb.2019.00015 |
Ejemplares similares
-
Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease
por: Paul, Ashim, et al.
Publicado: (2019) -
Metabolite medicine offers a path beyond lists of metabolites
por: Shaham-Niv, Shira, et al.
Publicado: (2021) -
Peptide- and Metabolite-Based Hydrogels: Minimalistic Approach for the Identification and Characterization of Gelating Building Blocks
por: Tiwari, Om Shanker, et al.
Publicado: (2023) -
Chemical Chaperones Modulate the Formation of Metabolite Assemblies
por: Adsi, Hanaa, et al.
Publicado: (2021) -
Design of Functional RGD Peptide-Based Biomaterials for Tissue Engineering
por: Kumar, Vijay Bhooshan, et al.
Publicado: (2023)